completely disappearing or being replaced by fibrous tissue, as can be demonstrated clearly in those patients with diffuse jejunoileitis when followed over the years (Cooke & Swan 1974) . Consequently, in my view, the term recurrence should be regarded as indicating either healing by fibrosis or reactivation of disease already present, rather than new and fresh involvement of previously healthy gut. It should therefore be realized that extensive resection of large amounts of apparently normal-appearing intestine will not prevent recurrence and that good results are just as likely to be obtained with limited resections, without the added risk of nutritional problems brought about by more extensive operations.
Disease activity Some measurement of this disease activity is essential for the long-term follow up of patients and assessment of response to treatment. There are, however, great difficulties in equating clinical experience with definitive laboratory values to provide an activity index without the use of some arbitrary clinical evalution of the patient's illness. Some have used variables resulting from an analysis of the factors on which experienced consultants based their judgments as to how ill the patient was (Jalan et al. 1971 , Best et al. 1976 . Such judgments can then be translated by suitable numerical weighting and statistical treatment, 'weighing the component factors so as to optimise the accuracy with which it predicts the physician's overall assessment', into a quantitative index. Others have used variables such as bowel frequency, pulse rate, fever and sedimentation rate, which allow some quantitative assessment, and attached arbitrary weightings to subjective interpretation of such factors as nausea, well-being or abdominal pain (Dearing et al. 1969 , Truelove & Witts 1955 , Willoughby et al. 1971 . However, some of the variables used bear no consistent relationship to clinical activity, in particular sedimentation rate. In one series, nearly half the seriously ill children had normal values (WerIin & Grand 1977) , whilst 15% of our patients seriously ill with either ulcerative colitis or Crohn's disease also had normal values. Such exceptions remove any confidence in the value of this variable for determining disease activity (Dearing et al. 1969 , Jensen et al. 1976 , Talsted & Gjone 1976 . The Crohn's disease activity index (Best et al. 1976) , most detailed and carefully planned, illustrates the difficulties and defects of indices based on arbitrary weightings in separating patients with mild disease from those in good health, however it is modified by statistical calculations. Thus, 31% of those classed clinically as having fair to good health and 6% of those whose health was poor fell within the index range allotted to those whose health was regarded as being very good, whilst 10% of those judged very well exceeded the upper limit of this category.
Surprisingly few workers have stressed the importance of serum albumin determinations as a reflection of disease activity in inflammatory bowel disease. Even when setting up the Crohn's disease activity index, serum albumin levels were not determined in 19.2% of patient attendances and in any event were excluded owing to a negative correlation. There are however, excellent reasons for regarding serum albumin estimations as essential for any assessment of disease activity. The excessive intestinal loss of albumin in some patients with hypoalbuminaemia was demonstrated in 1959 (Gordon 1959, Schwartz and Jarnum 1959) and later in patients with inflammatory bowel disease (Steinfeld et al. 1960 ). Furthermore, the increased catabolic rate of albumin demonstrated in these conditions correlates with this intestinal loss and inversely with the levels of serum albumin (Bendixen et al. 1968 ).Clinically, low serum levels are present when the patients are ill and normal when the disease is quiescent (Dearing et al. 1969 , Jensen et al. 1976 , Weeke & Jarnum 1971 .
The use of serum seromucoid estimations in addition to albumin as an indicator of disease activity was suggested in 1958 (Cooke et al. 1958) on demonstrating a close inverse correlation between these two determinations, with normal values when the patient was well and low values for serum albumin and high values of seromucoids when the patient was ill. More recently, it has been suggested that orosomucoid, a major component ofseromucoids, is the most accurate means of assessing disease activity in inflammatory bowel disease that is presently available (Dearing et al. 1969 , Jensen et al. 1976 , Hylander et al. 1976 . The validity of the correlation between seromucoid and albumin in these patients was strengthened by an analysis of 10 variables (albumin, globulin, alkaline phosphatase, seromucoid, weight, haemoglobin, iron, folic acid, B I 2 and mean corpuscular volume) on 176 patients giving more than 3500 sets of observations, showing that the relationship was not dependent upon weighting by other variables. In practice, these two determinations, albumin and seromucoids, have been used and recorded by us on data flow sheets for 20 years for the supervision and treatment of more than 1000 patients with Crohn's disease and ulcerative colitis to assess the degree that disease activity was responsible for our patients' clinical condition. However, the same criticism can still be made that the interpretation of these estimations was based on an arbitrary clinical assessment.
To minimize this criticism, the laboratory variables associated with the two clinical states least liable to disagreement and not needing deep analysis of the reasons for this assessment were studied in 86 patients (49 Crohn's disease, 37 ulcerative colitis), firstly when they wers eriously ill and secondly when they were completely well one to three years later; working, without symptoms, and of normal weight and energy. There was a clear cut separation of the levels of albumin and seromucoid in the two clinical states (serum albumin mean 28.3, range 17-39 g/l, when ill and mean 46.5, range 42-55 g/l, when well; serum seromucoid mean 3.58, range 2.0-6.0 g/l, when ill and mean 1.04, range 0.5-1.41 g/l, when well). Haemoglobin and sedimentation rate, however, though showing correlation with clinical assessment, showed considerable overlap in the two categories. In my view, therefore, these two estimations are essential in the routine supervisory follow up of these patients and for the meaningful evaluation of any specific therapy.
Mortality and the risk of dying Adequate advice on the treatment ofCrohn's disease cannot be given without an appreciation of the risks involved, whether from the disease itself or from therapy. Crude death rates without correction for age or for the period of observation are a misleading method of comparing different series, and actuarial (life table) methods are more generally used. Even so, there is still some variation in constructing such tables -as shown by the differing methods of selecting patients, whether by age, sex or site of disease at onset. The point in the life cycle at which analysis should be started varies. This can be the time of onset of symptoms; which depends upon retrospective recollection of the patient and which clearly omits those who do not come under the surveillance of that series; the time of diagnosis, which will introduce a small error in selection for those patients referred from another centre in that they had survived long enough from diagnosis to be referred; or lastly, the date first seen can be used, but is unsatisfactory since patients are liable to be included at greatly differing stages of their disease. In our view, date of diagnosis is the preferred method and one which is most likely to make comparisons between series easier (Prior et 01. 1981) .
Our material consisted of 513 patients who had been treated and followed up by me to the end of 1976 for an average of 14.5 years: 102 patients had died compared with the expected number of approximately 52 (Prior et 01. 1981) . The lessening chance of survival for both men and women is readily shown, with women initially having better survival curves than men, though at the end of 30 years the excess mortality in both becomes similar: It is, however, more meaningful to compare the cumulative deaths with the expected numbers to give the relative risk of dying (i.e. the ratio of the observed deaths to those expected). In the first 5 years from the date of diagnosis, the relative risk of dying is approximately 4 times that of the normal population; falling at the end of 15 years to that of the normal population. In relation to the age of diagnosis, the relative risk of dying is increased more than 4-fold in patients under the age of 30, 3-fold between the ages of 30 and 45 and becomes equal to that of the normal population in patients more than 45 years of age. These figures are similar to those from Stockholm (Hellers 1979) , derived from 826 patients with a mean follow up of9.5 years, of 6.25, 3.36 and 1.41 for the respective age periods.
These findings are opposite to the conclusions reached by the Oxford workers (Truelove & Pena 1976 ) that 'in terms of mortality, Crohn's disease emerges as a disease which becomes progressively more dangerous as the years go by', based on the finding of an increased cumulative excess mortality (i.e. the difference between observed and expected deaths). This is not an accepted statistical method for assessing risk over time. Indeed, in the Oxford series the relative risk of dying shows an approximate 2-fold increases at 5, 10 and 15 years of follow up, though whether from the onset of symptoms or from the date of diagnosis is not clear. The effects of age were also denied but again calculating the increased risk, there was a 6-fold increased risk for patients under the age of 40 which falls to 1.4 over that age, findings comparable to those in Birmingham and Stockholm. Two points must therefore be made. First, the' risks ofCrohn's disease get less, the older the patient is when the diagnosis is made; and secondly, the longer the patient has been diagnosed, the less are the risks of dying.
Surgical intervention
Views on the role of surgery vary from that originally put forward by Crohn and his colleagues (1932) , that the disease could be cured by adequate excision, to that which stated 'the consensus of opinion would seem to favour nonoperative therapy whenever possible as recurrence after surgery is great' (Reilly et al. 1976 ). The great differences in policy for surgical intervention are shown by the differing percentage of patients operated upon in different series. For example, the National Cooperative Crohn's disease study had only a 40% operative rate 41 months after diagnosis (Mekhjian et al. 1979a) , whilst in the following two years the operative rate at the 14 study centres showed only 73 operations amongst the 569 patients, with significantly different numbers at the study centres varying from nil among 29 patients to 25% of76 patients (Mekhjian et al. 1979b) . Enteroenteric fistulae, an indication for operation in the views of many, was performed in only 9 patients, whereas such fistulae had been demonstrated in 50 patients radiologically (Goldberg et al. 1979 ). Such operative rates should be compared with 90% at 5 years in Upsala and Birmingham, 95% at 10.5 years in Upsala and 96% at 24.5 years in Birmingham (Krause et al. 1971 , Bergman & Krause 1977 , Cooke et al. 1980 . Other series fall between these extremes. Such differences in operative policies can but invalidate assessments and comparisons of the results of therapy.
Operation has been claimed to increase the risks of a second operation, though the inclusion of a large number of bypass operations, which are more likely to be followed by recurrence than is resection, must be a factor (Greenstein et al. 1975 ). These claims are not supported by our own results (Cooke et al. 1980) which show that in anyone year there is a risk of operation of approximately 11% of the patients at risk for the first 5 years from diagnosis, falling to 7% over the next 10 and 6% over the succeeding 10 years. Recurrence rate is essentially similar after any of the first 5 operations for the first 10 years and they do not differ from one another in the rate of recurrence. In practical terms, a patient followed for 25 years after diagnosis has a 1 in 3 chance of having only one operation and a 1 in 4 chance of having only two operations. Patients less than 30 years of age at diagnosis have more recurrences than those over that age. Those under the age of 20 are more likely to have a history of less than 6 months with a probable recurrence rate of 70% than those over the age of 40 with only a 30% recurrence rate. There is, however, no relationship between the age at diagnosis and the interval to the first recurrence, as has been suggested by some, nor was there a trend to either more or less frequent recurrences after successive resections. Indeed, the likelihood of further operations being expedited by resection seems improbable, seeing that the patient is getting older and the time since diagnosis longer, so that recurrences should be less likely and the risks of dying should be approaching those of the normal population. There are differences in the definition of recurrence, but in my view it should be taken as the necessity for further definitive resection, recognizing that resection in some patients will be removing merely a burned out area of fibrotic tissue, the end stage of active Crohn's disease.
The possibility of producing the short bowel syndrome should never contraindicate operation if the surgical indications are present. Our own results in patients who have been left with less than 200 em small intestine (Cooke et al. 1980 ) support the views expressed by others (Atwell et al. 1965 , Kristensen et al. 1974 ) that in the course of time they regain their weight, energy and fitness for work and are not troubled with diarrhoea.
Medical therapy. It should occasion no surprise that little agreement exists concerning the" efficacy of medical treatment, or indeed the aims of medical therapy, in view of the influence of age at diagnosis and time since diagnosis on the mortality and recurrence rates, the great variation in policy towards surgical intervention, the differing methods of patient selection for the various series and the inadequate methods for assessing results of therapy. The National Cooperative Crohn's disease study illustrates many of the problems. The clinical material cannot be considered unselected, since patients at some centres were included as the result ofa circulated request for cases to outside consultants. Other patients had been diagnosed as long as 13 years before inclusion in the study, and the reasons why 515 patients, nearly half the patients under consideration, were excluded from randomization are difficult to discover. In claiming a favourable response to prednisone and sulfasalazine as assessed by their effect upon the activity index, a nonspecific effect on at least 4 of the 8 variables used in the index cannot be totally dismissed as a possible explanation . Of interest, a small group diagnosed -nearly 6 months prior to entering the study, but whose ages were not stated1 experienced no benefit from prednisone (Mekhjian et al. 1979a) . My own experience with the Birmingham series, which has as good results and mortality rates as other series and has been followed longer, showed that corticosteroids, immunosuppressives and sulfasalazine are not necessary in the majority of patients with Crohn's disease (Cooke et al. 1980) . I can but conclude that, if there is a specific therapy, it is the combination of surgery with adequate treatment of the haematological and secondary metabolic defects such as magnesium and zinc deficiency, for neither surgery nor medical therapy can succeed on their own. It must also be stressed that regular follow up is essential and that an important ingredient of therapy is patience combined with an optimistic attitude to the eventual outcome. Despite a view that 'Crohn's disease is a frightening diagnosis for both doctor and patient' (Gazzard et al. 1978) , the long term prognosis is good (Cooke et al. 1980) .
